XML 26 R81.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments and Fair Value Measurements (Schedules of Concentration of Risk) (Details)
3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended
Dec. 27, 2013
Distributor Concentration Risk
Net Sales Attributable to Distributors
Cardinal Health, Inc.
Dec. 28, 2012
Distributor Concentration Risk
Net Sales Attributable to Distributors
Cardinal Health, Inc.
Dec. 27, 2013
Distributor Concentration Risk
Net Sales Attributable to Distributors
McKesson Corporation
Dec. 28, 2012
Distributor Concentration Risk
Net Sales Attributable to Distributors
McKesson Corporation
Dec. 27, 2013
Distributor Concentration Risk
Net Sales Attributable to Distributors
Amerisource Bergen Corporation
Dec. 28, 2012
Distributor Concentration Risk
Net Sales Attributable to Distributors
Amerisource Bergen Corporation
Dec. 27, 2013
Distributor Concentration Risk
Accounts Receivable Attributable to Distributors
Cardinal Health, Inc.
Sep. 27, 2013
Distributor Concentration Risk
Accounts Receivable Attributable to Distributors
Cardinal Health, Inc.
Dec. 27, 2013
Distributor Concentration Risk
Accounts Receivable Attributable to Distributors
McKesson Corporation
Sep. 27, 2013
Distributor Concentration Risk
Accounts Receivable Attributable to Distributors
McKesson Corporation
Dec. 27, 2013
Distributor Concentration Risk
Accounts Receivable Attributable to Distributors
Amerisource Bergen Corporation
Sep. 27, 2013
Distributor Concentration Risk
Accounts Receivable Attributable to Distributors
Amerisource Bergen Corporation
Dec. 27, 2013
Product Concentration Risk
Net Sales Attributable to Products
Optiray (CMDS)
Dec. 28, 2012
Product Concentration Risk
Net Sales Attributable to Products
Optiray (CMDS)
Dec. 27, 2013
Product Concentration Risk
Net Sales Attributable to Products
Methylphenidate ER (Specialty Generics)
Dec. 28, 2012
Product Concentration Risk
Net Sales Attributable to Products
Methylphenidate ER (Specialty Generics)
Concentration Risk [Line Items]                                
Concentration risk, percentage 20.00% 22.00% 15.00% 15.00% 12.00% 8.00% 25.00% 18.00% 24.00% 22.00% 14.00% 14.00% 13.00% 16.00% 10.00% 2.00%